Mikhail Kagan

Mikhail Kagan

Auto-generated profile, based on publicly available information

Mikhail Kagan

State Autonomous Healthcare Institution “Regional Children’s Clinical Hospital,” Orenburg, Russian Federation

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2010 in Human Mutation
Verified
Journal Article
Open access
PDF file
VMVerena Matejas
Verena Matejas
BHBernward Hinkes
Bernward Hinkes
FAFaisal Alkandari
Faisal Alkandari
LALihadh Al-Gazali
Lihadh Al-Gazali
EAEllen Annexstad
Ellen Annexstad
MZMartin Zenker
Martin Zenker
Mutations of LAMB2 typically cause autosomal recessive Pierson syndrome, a disorder characterized by congenital nephrotic syndrome, ocular and neurologic abnormalities, but may occasionally be associated with milder or oligosymptomatic disease variants. LAMB2 encodes the basement membrane protein laminin β2, which is incorporated in specific heterotrimeric laminin isoforms and has an expression pattern corresponding to the pattern of organ manifestations in Pierson syndrome. Herein we review all previously reported and several novel LAMB2 mutations in relation to the associated phenotype in patients from 39 unrelated families. The majority of disease‐causing LAMB2 mutations are truncating, consistent with the hypothesis that loss of laminin β2 function is the molecular basis of Pierson syndrome. Although truncating mutations are distributed across the entire gene, missense mutations are clearly clustered in the N‐terminal LN domain, which is important for intermolecular interactions. There is an association of missense mutations and small in frame deletions with a higher mean age at onset of renal disease and with absence of neurologic abnormalities, thus suggesting that at least some of these may represent hypomorphic alleles. Nevertheless, genotype alone does not appear to explain the full range of clinical variability, and therefore hitherto unidentified modifiers are likely to exist. Hum Mutat 31:992–1002, 2010.

1 October 2008 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
CBCecilie Bredrup
Cecilie Bredrup
VMVerena Matejas
Verena Matejas
MBMargaret Barrow
Margaret Barrow
KBKvěta Bláhová
Květa Bláhová
DBDetlef Bockenhauer
Detlef Bockenhauer
IRIsabelle Russell-Eggitt
Isabelle Russell-Eggitt

18 October 2007 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
MKMikhail Kagan
Mikhail Kagan
ACArthur H. Cohen
Arthur H. Cohen
VMVerena Matejas
Verena Matejas
CVChristopher Vlangos
Christopher Vlangos
MZMartin Zenker
Martin Zenker

15 August 2007 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HRHeike Radeke
Heike Radeke
KHKelley Hanson
Kelley Hanson
PYPadmaja Yalamanchili
Padmaja Yalamanchili
MHMegan Hayes
Megan Hayes
ZZZhi-Qin Zhang
Zhi-Qin Zhang
DCDavid Casebier
David Casebier

1 June 2011 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
MKMikhail Kagan
Mikhail Kagan
NBNataliya Bervina
Nataliya Bervina
OVOLGA VOROBYEVA
OLGA VOROBYEVA
CWCarine Wouters
Carine Wouters
ELElena Levtchenko
Elena Levtchenko

15 June 2012 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
MKM. Y. Kagan
M. Y. Kagan
NSN. S. Shulakova
N. S. Shulakova
RGR. A. Gumirova
R. A. Gumirova
EZE. A. Zlodeeva
E. A. Zlodeeva
NRN. V. Resnick
N. V. Resnick
Синдром Ниймеген — редкое аутосомно-рецессивное заболевание, проявляющееся врожденной микроцефалией, дисморфичным лицом, комбинированным иммунодефицитом и предрасположенностью к развитию злокачественных новообразований. Заболевание является следствием мутации гена NBN, имеет распространение преимущественно среди славянских народов, у которых большинство поврежденных аллелей содержит делецию 5 пар оснований (c.657_661del5). Приводим результаты наблюдения за ребенком, у которого синдром Ниймеген осложнился острым лимфобластным лейкозом.